Publication:
Augmenting and Directing Robust, Long-Range CRISPR-Mediated Activation in Human Cells

No Thumbnail Available

Date

2021-08-05

Journal Title

Journal ISSN

Volume Title

Publisher

Springer Science and Business Media LLC
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Tak, Y. Esther, Joy E Horng, Nicholas T Perry, Hayley T Schultz, Sowmya Iyer, Qiuming Yao, Luli S Zou, Martin J Aryee, Luca Pinello, and J. Keith Joung. 2021. “Augmenting and Directing Long-Range CRISPR-Mediated Activation in Human Cells.” Nature Methods 18 (9): 1075–81.

Research Data

Abstract

Epigenetic editing is an emerging technology that uses artificial transcription factors (aTFs) to regulate expression of a target gene. Although human genes can be robustly upregulated by targeting aTFs to promoters, the activation induced by targeting aTFs to distal transcriptional enhancers is substantially less robust and consistent. Here we show that long-range activation using CRISPR-based aTFs in human cells can be made more efficient and reliable by concurrently targeting an aTF to the target gene promoter. We used this strategy to direct target gene choice for enhancers capable of regulating more than one promoter and to achieve allele-selective activation of human genes by targeting aTFs to SNPs embedded in distally located sequences. Our results broaden the potential applications of the epigenetic editing toolbox for research and therapeutics.

Description

Other Available Sources

Keywords

Cell Biology, Molecular Biology, Biochemistry, Biotechnology

Terms of Use

Metadata Only

Endorsement

Review

Supplemented By

Referenced By

Related Stories